CYCLOSPORINE/CHONDROITIN SULFATE PF emulsion

البلد: الولايات المتحدة

اللغة: الإنجليزية

المصدر: NLM (National Library of Medicine)

اشتر الآن

خصائص المنتج خصائص المنتج (SPC)
26-02-2018

العنصر النشط:

CYCLOSPORINE (UNII: 83HN0GTJ6D) (CYCLOSPORINE - UNII:83HN0GTJ6D)

متاح من:

ImprimisRx NJ

INN (الاسم الدولي):

CYCLOSPORINE

تركيب:

CYCLOSPORINE 1 mg in 1 mL

طريقة التعاطي:

OPHTHALMIC

نوع الوصفة الطبية :

PRESCRIPTION DRUG

الوضع إذن:

unapproved drug other

خصائص المنتج

                                CYCLOSPORINE/CHONDROITIN SULFATE PF- CYCLOSPORINE/CHONDROITIN SULFATE
PF EMULSION
IMPRIMISRX NJ
_Disclaimer: This drug has not been found by FDA to be safe and
effective, and this labeling has not been_
_approved by FDA. For further information about unapproved drugs,
click here._
----------
STORE AT 20° TO 25° C (68° TO 77° F)
CYCLOSPORINE/CHONDROITIN SULFATE PF
cyclosporine/chondroitin sulfate pf emulsion
PRODUCT INFORMATION
PRODUCT T YPE
HUMAN PRESCRIPTION DRUG
ITE M CODE (SOURCE )
NDC:70 26 1-514
ROUTE OF ADMINISTRATION
OPHTHALMIC
ACTIVE INGREDIENT/ACTIVE MOIETY
INGREDIENT NAME
BASIS OF STRENGTH
STRE NG TH
CYCLO SPO RINE (UNII: 8 3HN0 GTJ6 D) (CYCLOSPORINE - UNII:8 3HN0 GTJ6
D)
CYCLOSPORINE
1 mg in 1 mL
PACKAG ING
#
ITEM CODE
PACKAGE DESCRIPTION
MARKETING START
DATE
MARKETING END
DATE
1
NDC:70 26 1-514-
0 5
5.5 mL in 1 BOTTLE, DROPPER; Type 0 : No t a Co mbinatio n
Pro duc t
0 2/0 1/20 18
MARKETING INFORMATION
MARKE TING CATE GORY
APPLICATION NUMBE R OR MONOGRAPH CITATION
MARKE TING START DATE
MARKE TING END DATE
unappro ved drug o ther
0 2/0 1/20 18
ImprimisRx NJ
LABELER -
ImprimisRx NJ (931390178)
Revised: 2/2018
                                
                                اقرأ الوثيقة كاملة
                                
                            

تنبيهات البحث المتعلقة بهذا المنتج